This article was automatically generated by Dow Jones using technology from Automated Insights.
Shares of Moderna Inc. rose 5.3% to $35.53 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 2.2% to 19,524.01 and Dow Jones Industrial Average falling 1.7% to 43,428.02.
Moderna Inc. closed 79.2% below its 52-week high of $170.47, which the company achieved on May 24th.
The stock outperformed some of its competitors, as Johnson & Johnson rose 1.6% to $162.30, Pfizer Inc. rose 1.5% to $26.30, and Gilead Sciences Inc. fell 0.07% to $109.95.
Trading volume totaled 21.0 million, compared to the 50-day average of 11.3 million.
Data source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
February 21, 2025 16:35 ET (21:35 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。